BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36765408)

  • 61. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001.
    Soerjomataram I; Louwman WJ; de Vries E; Lemmens VE; Klokman WJ; Coebergh JW
    Breast Cancer Res Treat; 2005 Sep; 93(1):91-5. PubMed ID: 16184464
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC).
    Ricceri F; Fasanelli F; Giraudo MT; Sieri S; Tumino R; Mattiello A; Vagliano L; Masala G; Quirós JR; Travier N; Sánchez MJ; Larranaga N; Chirlaque MD; Ardanaz E; Tjonneland A; Olsen A; Overvad K; Chang-Claude J; Kaaks R; Boeing H; Clavel-Chapelon F; Kvaskoff M; Dossus L; Trichopoulou A; Benetou V; Adarakis G; Bueno-de-Mesquita HB; Peeters PH; Sund M; Andersson A; Borgquist S; Butt S; Weiderpass E; Skeie G; Khaw KT; Travis RC; Rinaldi S; Romieu I; Gunter M; Kadi M; Riboli E; Vineis P; Sacerdote C
    Int J Cancer; 2015 Aug; 137(4):940-8. PubMed ID: 25650288
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Declining second primary ovarian cancer after first primary breast cancer.
    Schonfeld SJ; Berrington de Gonzalez A; Visvanathan K; Pfeiffer RM; Anderson WF
    J Clin Oncol; 2013 Feb; 31(6):738-43. PubMed ID: 23284037
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
    Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
    JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The risk of developing second primary malignancies among colorectal cancer patients.
    Du S; Li Y; Sun H; Deng G; Tang S; Zeng F; Zhang B; Cui B
    Aging (Albany NY); 2022 Aug; 14(16):6756-6779. PubMed ID: 36036758
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.
    Sackey H; Hui M; Czene K; Verkooijen H; Edgren G; Frisell J; Hartman M
    Breast Cancer Res; 2016 Oct; 18(1):105. PubMed ID: 27756431
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Second neoplasms after invasive and borderline ovarian cancer.
    Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
    Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population-based analysis.
    Lai YL; Chiang CJ; Chen YL; You SL; Chen YY; Chiang YC; Tai YJ; Hsu HC; Chen CA; Cheng WF
    Cancer Med; 2021 Oct; 10(19):6845-6854. PubMed ID: 34523816
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
    Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk of second primary cancer in men with breast cancer.
    Satram-Hoang S; Ziogas A; Anton-Culver H
    Breast Cancer Res; 2007; 9(1):R10. PubMed ID: 17254323
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Second primaries after major salivary gland cancer.
    Megwalu UC; Shin EJ
    Otolaryngol Head Neck Surg; 2011 Aug; 145(2):254-8. PubMed ID: 21493280
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012.
    Crocetti E; Mattioli V; Buzzoni C; Franceschi S; Serraino D; Vaccarella S; Ferretti S; Busco S; Fedeli U; Varvarà M; Falcini F; Zorzi M; Carrozzi G; Mazzucco W; Gasparotti C; Iacovacci S; Toffolutti F; Cavallo R; Stracci F; Russo AG; Caldarella A; Rosso S; Musolino A; Mangone L; Casella C; Fusco M; Tagliabue G; Piras D; Tumino R; Guarda L; Dinaro YM; Piffer S; Pinna P; Mazzoleni G; Fanetti AC; Dal Maso L;
    Cancer Med; 2021 Oct; 10(19):6855-6867. PubMed ID: 34533289
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients.
    Muller J; Grosclaude P; Lapôtre-Ledoux B; Woronoff AS; Guizard AV; Bara S; Colonna M; Troussard X; Bouvier V; Trétarre B; Velten M; Jégu J
    BJU Int; 2016 Jul; 118(1):53-9. PubMed ID: 26469096
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.
    Schonfeld SJ; Morton LM; Berrington de González A; Curtis RE; Kitahara CM
    Cancer Epidemiol; 2020 Feb; 64():101664. PubMed ID: 31884334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Second primary gynecologic cancers after breast cancer in Turkish women.
    Gulhan I; Eser S; Yakut C; Bige O; Ilhan E; Yildirim Y; Saygili U
    Int J Gynecol Cancer; 2009 May; 19(4):648-50. PubMed ID: 19509564
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of second primary cancers among survivors of gynecological cancers.
    Adjei Boakye E; Grubb L; Peterson CE; Osazuwa-Peters N; Grabosch S; Ladage HD; Huh WK
    Gynecol Oncol; 2020 Sep; 158(3):719-726. PubMed ID: 32616403
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
    Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
    BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Incidence of breast cancer in women with multiple sclerosis: systematic review and meta-analysis of observational cohort studies].
    Catalá-López F; Tobías A
    Rev Neurol; 2010 Nov; 51(9):513-9. PubMed ID: 20979030
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup.
    Allodji RS; Hawkins MM; Bright CJ; Fidler-Benaoudia MM; Winter DL; Alessi D; Fresneau B; Journy N; Morsellino V; Bárdi E; Bautz A; Byrne J; Feijen ELA; Teepen JC; Vu-Bezin G; Rubino C; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Hau EM; Jankovic M; Kaatsch P; Kaiser M; Linge H; Muraca M; Llanas D; Veres C; Øfstaas H; Diallo I; Mansouri I; Ronckers CM; Skinner R; Terenziani M; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuehni CE; Winther JF; Michel G; Kremer LCM; Hjorth L; Haddy N; de Vathaire F; Reulen RC
    Eur J Cancer; 2019 Aug; 117():71-83. PubMed ID: 31260818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.